Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

This article is the first in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation and venous thromboembolism.

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Trending on AJMC

NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants

Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG

FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome

How Effective and Safe Are GLP-1s for Weight Loss?

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD